CORRECTION – Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

RA'ANANA, Israel, June 05, 2025 (GLOBE NEWSWIRE) — RA’ANANA, Israel, June 5, 2025 — Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company“), a pioneer in innovative life-support and diagnostic technologies, today announced preparations for scaled-up its production capabilities for its U.S. Food and Drug Administration (FDA)-cleared INSPIRA™ ART100 system (the “ART100 system”), in response to expected demand from a European governmental authority with which the Company is currently in advanced-stage procurement negotiations.

Source: https://www.globenewswire.com/news-release/2025/06/05/3094567/0/en/CORRECTION-Inspira-Scales-Up-ART100-Production-Capabilities-Amid-Advanced-Negotiation-with-European-Government-Authority.html